Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas
详细信息    查看全文
  • 作者:Yanwen Jiang (1) (2)
    David Redmond (1)
    Kui Nie (3)
    Ken W Eng (1)
    Thomas Clozel (4)
    Peter Martin (2)
    Leonard HC Tan (5)
    Ari M Melnick (2)
    Wayne Tam (3)
    Olivier Elemento (1)

    1. Institute for Computational Biomedicine
    ; Weill Cornell Medical College ; New York ; NY ; 10021 ; USA
    2. Department of Medicine
    ; Weill Cornell Medical College ; New York ; NY ; 10021 ; USA
    3. Department of Pathology and Laboratory Medicine
    ; Weill Cornell Medical College ; New York ; NY ; 10021 ; USA
    4. Hematology
    ; Lymphoid Unit ; H么pital Henri Mondor ; Creteil ; 94010 ; France
    5. Department of Pathology
    ; Singapore General Hospital ; Singapore ; 169608 ; Singapore
  • 刊名:Genome Biology
  • 出版年:2014
  • 出版时间:August 2014
  • 年:2014
  • 卷:15
  • 期:8
  • 全文大小:1,685 KB
  • 参考文献:1. Coiffier, B, Lepage, E, Briere, J, Herbrecht, R, Tilly, H, Bouabdallah, R, Morel, P, Neste, E, Salles, G, Gaulard, P, Reyes, F, Lederlin, P, Gisselbrecht, C (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346: pp. 235-242 CrossRef
    2. Larouche, JF, Berger, F, Chassagne-Clement, C, Ffrench, M, Callet-Bauchu, E, Sebban, C, Ghesquieres, H, Broussais-Guillaumot, F, Salles, G, Coiffier, B (2010) Lymphoma recurrence 5聽years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome. J Clin Oncol 28: pp. 2094-2100 CrossRef
    3. Gisselbrecht, C, Glass, B, Mounier, N, Singh Gill, D, Linch, DC, Trneny, M, Bosly, A, Ketterer, N, Shpilberg, O, Hagberg, H, Ma, D, Briere, J, Moskowitz, CH, Schmitz, N (2010) Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol 28: pp. 4184-4190 CrossRef
    4. Friedberg, JW (2011) Relapsed/refractory diffuse large B-cell lymphoma. Hematology Am Soc Hematol Educ Program 2011: pp. 498-505 CrossRef
    5. Ding, L, Ley, TJ, Larson, DE, Miller, CA, Koboldt, DC, Welch, JS, Ritchey, JK, Young, MA, Lamprecht, T, McLellan, MD, McMichael, JF, Wallis, JW, Lu, C, Shen, D, Harris, CC, Dooling, DJ, Fulton, RS, Fulton, LL, Chen, K, Schmidt, H, Kalicki-Veizer, J, Magrini, VJ, Cook, L, McGrath, SD, Vickery, TL, Wendl, MC, Heath, S, Watson, MA, Link, DC, Tomasson, MH (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481: pp. 506-510 38/nature10738" target="_blank" title="It opens in new window">CrossRef
    6. Jung, D, Alt, FW (2004) Unraveling V(D)J recombination; insights into gene regulation. Cell 116: pp. 299-311 39-X" target="_blank" title="It opens in new window">CrossRef
    7. Berek, C, Berger, A, Apel, M (1991) Maturation of the immune response in germinal centers. Cell 67: pp. 1121-1129 CrossRef
    8. Jacob, J, Kelsoe, G, Rajewsky, K, Weiss, U (1991) Intraclonal generation of antibody mutants in germinal centres. Nature 354: pp. 389-392 38/354389a0" target="_blank" title="It opens in new window">CrossRef
    9. Lefranc, MP, Giudicelli, V, Ginestoux, C, Jabado-Michaloud, J, Folch, G, Bellahcene, F, Wu, Y, Gemrot, E, Brochet, X, Lane, J, Regnier, L, Ehrenmann, F, Lefranc, G, Duroux, P (2009) IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 37: pp. D1006-D1012 3/nar/gkn838" target="_blank" title="It opens in new window">CrossRef
    10. Gawad, C, Pepin, F, Carlton, VE, Klinger, M, Logan, AC, Miklos, DB, Faham, M, Dahl, G, Lacayo, N (2012) Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. Blood 120: pp. 4407-4417 CrossRef
    11. Yancopoulos, GD, Alt, FW (1986) Regulation of the assembly and expression of variable-region genes. Annu Rev Immunol 4: pp. 339-368 CrossRef
    12. Arnaout R, Lee W, Cahill P, Honan T, Sparrow T, Weiand M, Nusbaum C, Rajewsky K, Koralov SB: High-resolution description of antibody heavy-chain repertoires in humans. / PLoS One 2011, 6:e22365.
    13. Saitou, N, Nei, M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: pp. 406-425
    14. Jiang Y, Soong TD, Wang L, Melnick AM, Elemento O: Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma. / PLoS One 2012, 7:e40332.
    15. Wacker, SA, Houghtaling, BR, Elemento, O, Kapoor, TM (2012) Using transcriptome sequencing to identify mechanisms of drug action and resistance. Nat Chem Biol 8: pp. 235-237 38/nchembio.779" target="_blank" title="It opens in new window">CrossRef
    16. Rajadhyaksha, AM, Elemento, O, Puffenberger, EG, Schierberl, KC, Xiang, JZ, Putorti, ML, Berciano, J, Poulin, C, Brais, B, Michaelides, M, Weleber, RG, Higgins, JJ (2010) Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa. Am J Hum Genet 87: pp. 643-654 3" target="_blank" title="It opens in new window">CrossRef
    17. Lohr, JG, Stojanov, P, Lawrence, MS, Auclair, D, Chapuy, B, Sougnez, C, Cruz-Gordillo, P, Knoechel, B, Asmann, YW, Slager, SL, Novak, AJ, Dogan, A, Ansell, SM, Link, BK, Zou, L, Gould, J, Saksena, G, Stransky, N, Rangel-Escareno, C, Fernandez-Lopez, JC, Hidalgo-Miranda, A, Melendez-Zajgla, J, Hernandez-Lemus, E, Schwarz-Cruz y Celis, A, Imaz-Rosshandler, I, Ojesina, AI, Jung, J, Pedamallu, CS, Lander, ES, Habermann, TM (2012) Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A 109: pp. 3879-3884 3/pnas.1121343109" target="_blank" title="It opens in new window">CrossRef
    18. Pasqualucci, L, Trifonov, V, Fabbri, G, Ma, J, Rossi, D, Chiarenza, A, Wells, VA, Grunn, A, Messina, M, Elliot, O, Chan, J, Bhagat, G, Chadburn, A, Gaidano, G, Mullighan, CG, Rabadan, R, Dalla-Favera, R (2011) Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 43: pp. 830-837 38/ng.892" target="_blank" title="It opens in new window">CrossRef
    19. Morin, RD, Mendez-Lago, M, Mungall, AJ, Goya, R, Mungall, KL, Corbett, RD, Johnson, NA, Severson, TM, Chiu, R, Field, M, Jackman, S, Krzywinski, M, Scott, DW, Trinh, DL, Tamura-Wells, J, Li, S, Firme, MR, Rogic, S, Griffith, M, Chan, S, Yakovenko, O, Meyer, IM, Zhao, EY, Smailus, D, Moksa, M, Chittaranjan, S, Rimsza, L, Brooks-Wilson, A, Spinelli, JJ, Ben-Neriah, S (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476: pp. 298-303 38/nature10351" target="_blank" title="It opens in new window">CrossRef
    20. Zhang, J, Grubor, V, Love, CL, Banerjee, A, Richards, KL, Mieczkowski, PA, Dunphy, C, Choi, W, Au, WY, Srivastava, G, Lugar, PL, Rizzieri, DA, Lagoo, AS, Bernal-Mizrachi, L, Mann, KP, Flowers, C, Naresh, K, Evens, A, Gordon, LI, Czader, M, Gill, JI, Hsi, ED, Liu, Q, Fan, A, Walsh, K, Jima, D, Smith, LL, Johnson, AJ, Byrd, JC, Luftig, MA (2013) Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A 110: pp. 1398-1403 3/pnas.1205299110" target="_blank" title="It opens in new window">CrossRef
    21. Beguelin, W, Popovic, R, Teater, M, Jiang, Y, Bunting, KL, Rosen, M, Shen, H, Yang, SN, Wang, L, Ezponda, T, Martinez-Garcia, E, Zhang, H, Zheng, Y, Verma, SK, McCabe, MT, Ott, HM, Aller, GS, Kruger, RG, Liu, Y, McHugh, CF, Scott, DW, Chung, YR, Kelleher, N, Shaknovich, R, Creasy, CL, Gascoyne, RD, Wong, KK, Cerchietti, L, Levine, RL, Abdel-Wahab, O (2013) EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 23: pp. 677-692 3.04.011" target="_blank" title="It opens in new window">CrossRef
    22. Olshen, AB, Venkatraman, ES, Lucito, R, Wigler, M (2004) Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5: pp. 557-572 3/biostatistics/kxh008" target="_blank" title="It opens in new window">CrossRef
    23. Lonigro, RJ, Grasso, CS, Robinson, DR, Jing, X, Wu, YM, Cao, X, Quist, MJ, Tomlins, SA, Pienta, KJ, Chinnaiyan, AM (2011) Detection of somatic copy number alterations in cancer using targeted exome capture sequencing. Neoplasia 13: pp. 1019-1025
    24. Challa-Malladi, M, Lieu, YK, Califano, O, Holmes, AB, Bhagat, G, Murty, VV, Dominguez-Sola, D, Pasqualucci, L, Dalla-Favera, R (2011) Combined genetic inactivation of beta2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell 20: pp. 728-740 CrossRef
    25. Manser, E, Loo, TH, Koh, CG, Zhao, ZS, Chen, XQ, Tan, L, Tan, I, Leung, T, Lim, L (1998) PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol Cell 1: pp. 183-192 CrossRef
    26. Harden, TK, Hicks, SN, Sondek, J (2009) Phospholipase C isozymes as effectors of Ras superfamily GTPases. J Lipid Res 50: pp. S243-S248 CrossRef
    27. Dumont, C, Henderson, R, Tybulewicz, VL (2008) Characterization of the roles of Rac1 and Rac2 GTPases in lymphocyte development. Methods Enzymol 439: pp. 235-254 CrossRef
    28. Johmura, S, Oh-hora, M, Inabe, K, Nishikawa, Y, Hayashi, K, Vigorito, E, Kitamura, D, Turner, M, Shingu, K, Hikida, M, Kurosaki, T (2003) Regulation of Vav localization in membrane rafts by adaptor molecules Grb2 and BLNK. Immunity 18: pp. 777-787 3(03)00139-0" target="_blank" title="It opens in new window">CrossRef
    29. Demoulin, JB, Uyttenhove, C, Roost, E, DeLestre, B, Donckers, D, Snick, J, Renauld, JC (1996) A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol Cell Biol 16: pp. 4710-4716
    30. O鈥橲hea, JJ, Holland, SM, Staudt, LM (2013) JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 368: pp. 161-170 CrossRef
    31. Goodarzi, H, Elemento, O, Tavazoie, S (2009) Revealing global regulatory perturbations across human cancers. Mol Cell 36: pp. 900-911 CrossRef
    32. Young, RM, Staudt, LM (2013) Targeting pathological B cell receptor signalling in lymphoid malignancies. Nat Rev Drug Discov 12: pp. 229-243 38/nrd3937" target="_blank" title="It opens in new window">CrossRef
    33. Xu-Monette, ZY, Wu, L, Visco, C, Tai, YC, Tzankov, A, Liu, WM, Montes-Moreno, S, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, KL, Hsi, ED, Zhao, XF, Choi, WW, Zhao, X, Krieken, JH, Huang, Q, Huh, J, Ai, W, Ponzoni, M, Ferreri, AJ, Zhou, F, Kahl, BS, Winter, JN, Xu, W, Li, J, Go, RS, Li, Y (2012) Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study. Blood 120: pp. 3986-3996 33334" target="_blank" title="It opens in new window">CrossRef
    34. Freeman, JD, Warren, RL, Webb, JR, Nelson, BH, Holt, RA (2009) Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res 19: pp. 1817-1824 CrossRef
    35. Boyd, SD, Gaeta, BA, Jackson, KJ, Fire, AZ, Marshall, EL, Merker, JD, Maniar, JM, Zhang, LN, Sahaf, B, Jones, CD, Simen, BB, Hanczaruk, B, Nguyen, KD, Nadeau, KC, Egholm, M, Miklos, DB, Zehnder, JL, Collins, AM (2010) Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements. J Immunol 184: pp. 6986-6992 CrossRef
    36. Campbell, PJ, Pleasance, ED, Stephens, PJ, Dicks, E, Rance, R, Goodhead, I, Follows, GA, Green, AR, Futreal, PA, Stratton, MR (2008) Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc Natl Acad Sci U S A 105: pp. 13081-13086 3/pnas.0801523105" target="_blank" title="It opens in new window">CrossRef
    37. Boyd SD, Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, Jones CD, Simen BB, Hanczaruk B, Nguyen KD, Nadeau KC, Egholm M, Miklos DB, Zehnder JL, Fire AZ: Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. / Sci Transl Med 2009, 1:12ra23.
    38. Logan, AC, Gao, H, Wang, C, Sahaf, B, Jones, CD, Marshall, EL, Buno, I, Armstrong, R, Fire, AZ, Weinberg, KI, Mindrinos, M, Zehnder, JL, Boyd, SD, Xiao, W, Davis, RW, Miklos, DB (2011) High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment. Proc Natl Acad Sci U S A 108: pp. 21194-21199 3/pnas.1118357109" target="_blank" title="It opens in new window">CrossRef
    39. Jong, D, Glas, AM, Boerrigter, L, Hermus, MC, Dalesio, O, Willemse, E, Nederlof, PM, Kersten, MJ (2003) Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell features. Blood 102: pp. 324-327 CrossRef
    40. Pasqualucci, L, Khiabanian, H, Fangazio, M, Vasishtha, M, Messina, M, Holmes, AB, Ouillette, P, Trifonov, V, Rossi, D, Tabbo, F, Ponzoni, M, Chadburn, A, Murty, VV, Bhagat, G, Gaidano, G, Inghirami, G, Malek, SN, Rabadan, R, Dalla-Favera, R (2014) Genetics of follicular lymphoma transformation. Cell Rep 6: pp. 130-140 3.12.027" target="_blank" title="It opens in new window">CrossRef
    41. Morin, RD, Johnson, NA, Severson, TM, Mungall, AJ, An, J, Goya, R, Paul, JE, Boyle, M, Woolcock, BW, Kuchenbauer, F, Yap, D, Humphries, RK, Griffith, OL, Shah, S, Zhu, H, Kimbara, M, Shashkin, P, Charlot, JF, Tcherpakov, M, Corbett, R, Tam, A, Varhol, R, Smailus, D, Moksa, M, Zhao, Y, Delaney, A, Qian, H, Birol, I, Schein, J, Moore, R (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42: pp. 181-185 38/ng.518" target="_blank" title="It opens in new window">CrossRef
    42. Green, MR, Gentles, AJ, Nair, RV, Irish, JM, Kihira, S, Liu, CL, Kela, I, Hopmans, ES, Myklebust, JH, Ji, H, Plevritis, SK, Levy, R, Alizadeh, AA (2013) Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 121: pp. 1604-1611 3" target="_blank" title="It opens in new window">CrossRef
    43. Mar BG, Bullinger LB, McLean KM, Grauman PV, Harris MH, Stevenson K, Neuberg DS, Sinha AU, Sallan SE, Silverman LB, Kung AL: Lo Nigro L, Ebert BL, Armstrong SA: Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia. / Nat Commun 2014, 5:3469.
    44. Mullighan, CG, Zhang, J, Kasper, LH, Lerach, S, Payne-Turner, D, Phillips, LA, Heatley, SL, Holmfeldt, L, Collins-Underwood, JR, Ma, J, Buetow, KH, Pui, CH, Baker, SD, Brindle, PK, Downing, JR (2011) CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471: pp. 235-239 38/nature09727" target="_blank" title="It opens in new window">CrossRef
    45. Oricchio, E, Nanjangud, G, Wolfe, AL, Schatz, JH, Mavrakis, KJ, Jiang, M, Liu, X, Bruno, J, Heguy, A, Olshen, AB, Socci, ND, Teruya-Feldstein, J, Weis-Garcia, F, Tam, W, Shaknovich, R, Melnick, A, Himanen, JP, Chaganti, RS, Wendel, HG (2011) The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell 147: pp. 554-564 35" target="_blank" title="It opens in new window">CrossRef
    46. Davis, RE, Ngo, VN, Lenz, G, Tolar, P, Young, RM, Romesser, PB, Kohlhammer, H, Lamy, L, Zhao, H, Yang, Y, Xu, W, Shaffer, AL, Wright, G, Xiao, W, Powell, J, Jiang, JK, Thomas, CJ, Rosenwald, A, Ott, G, Muller-Hermelink, HK, Gascoyne, RD, Connors, JM, Johnson, NA, Rimsza, LM, Campo, E, Jaffe, ES, Wilson, WH, Delabie, J, Smeland, EB, Fisher, RI (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463: pp. 88-92 38/nature08638" target="_blank" title="It opens in new window">CrossRef
    47. Fowler, N, Davis, E (2013) Targeting B-cell receptor signaling: changing the paradigm. Hematology Am Soc Hematol Educ Program 2013: pp. 553-560 3.1.553" target="_blank" title="It opens in new window">CrossRef
    48. Li, H, Durbin, R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: pp. 1754-1760 3/bioinformatics/btp324" target="_blank" title="It opens in new window">CrossRef
    49. NCBI database BioProject PRJNA240335. [335" class="a-plus-plus">http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA240335]
    50. NBCI database BioProject PRJNA240336. [336" class="a-plus-plus">http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA240336]
  • 刊物主题:Animal Genetics and Genomics; Human Genetics; Plant Genetics & Genomics; Microbial Genetics and Genomics; Fungus Genetics; Bioinformatics;
  • 出版者:BioMed Central
  • ISSN:1465-6906
文摘
Background Molecular mechanisms associated with frequent relapse of diffuse large B-cell lymphoma (DLBCL) are poorly defined. It is especially unclear how primary tumor clonal heterogeneity contributes to relapse. Here, we explore unique features of B-cell lymphomas - VDJ recombination and somatic hypermutation - to address this question. Results We performed high-throughput sequencing of rearranged VDJ junctions in 14 pairs of matched diagnosis-relapse tumors, among which 7 pairs were further characterized by exome sequencing. We identify two distinctive modes of clonal evolution of DLBCL relapse: an early-divergent mode in which clonally related diagnosis and relapse tumors diverged early and developed in parallel; and a late-divergent mode in which relapse tumors developed directly from diagnosis tumors with minor divergence. By examining mutation patterns in the context of phylogenetic information provided by VDJ junctions, we identified mutations in epigenetic modifiers such as KMT2D as potential early driving events in lymphomagenesis and immune escape alterations as relapse-associated events. Conclusions Altogether, our study for the first time provides important evidence that DLBCL relapse may result from multiple, distinct tumor evolutionary mechanisms, providing rationale for therapies for each mechanism. Moreover, this study highlights the urgent need to understand the driving roles of epigenetic modifier mutations in lymphomagenesis, and immune surveillance factor genetic lesions in relapse.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700